Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy | |
Wang, Xiaoyun[1,2,3]; Wu, Fengbo[1,2,3]; Li, Guoyou[4]; Zhang, Nan[1,2,3]; Song, Xiangrong[1,2,3]; Zheng, Yu[1,2,3]; Gong, Changyang[1,2,3]; Han, Bo[5]; He, Gu[1,2,3] | |
2018 | |
卷号 | 74页码:414-429 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000437998200032 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4320386 |
专题 | 成都中医药大学 |
作者单位 | 1.[1]Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan, Peoples R China 2.[2]Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China 3.[3]Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China 4.[4]Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610065, Sichuan, Peoples R China 5.[5]Chengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Breeding Base Systemat Res Dev & Ut, Chengdu 611137, Sichuan, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Xiaoyun[1,2,3],Wu, Fengbo[1,2,3],Li, Guoyou[4],et al. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy[J],2018,74:414-429. |
APA | Wang, Xiaoyun[1,2,3].,Wu, Fengbo[1,2,3].,Li, Guoyou[4].,Zhang, Nan[1,2,3].,Song, Xiangrong[1,2,3].,...&He, Gu[1,2,3].(2018).Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.,74,414-429. |
MLA | Wang, Xiaoyun[1,2,3],et al."Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy".74(2018):414-429. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论